Local News

• Johnson & Johnson extends tender offer for Mentor Corporation  Johnson & Johnson announced it has extended its previously announced cash tender offer, through its wholly owned subsidiary, Maple Merger Sub, for all outstanding shares of common stock of Mentor Corporation until 5:00 p.m. (Eastern time), on January 16, 2009, unless further extended.
  Johnson & Johnson January 06, 2009  
• Monsanto announces yield gains with Deltapine Class Of 09  Monsanto Company announced its D&PL business will market five new varieties as the Deltapine Class of 09 for the coming production season. These varieties were introduced during the 2009 Beltwide Cotton Conferences that have brought the cotton industry together in San Antonio.
  Monsanto Company January 06, 2009  
• Implant Sciences appoints Glenn D. Bolduc as President and Chief Executive Officer  Implant Sciences announced the appointment of Glenn D. Bolduc as the Company's new President and Chief Executive Officer. In addition, the Board of Directors has appointed Mr. Bolduc as a member of the Board.
  Implant Sciences Corporation January 06, 2009  
• AdvanSource Biomaterials' antimicrobials patent application published by Patent Office  AdvanSource Biomaterials announced notification of the publication by the U.S. Patent and Trademark Office of the Company's U.S. patent application related to antimicrobial polyurethane polymers.
  AdvanSource Biomaterials Corporation January 06, 2009  
• Abbott completes acquisition of Ibis Biosciences, a subsidiary of Isis  Isis Pharmaceuticals and Abbott announced that Abbott has completed its purchase of Ibis Biosciences, an Isis subsidiary, for a closing purchase price of $175 million.
  Isis Pharmaceuticals, Inc. January 06, 2009  
• Boston Scientific acquires Labcoat Limited  Boston Scientific announced that it has acquired Labcoat Limited, a privately held, development-stage drug-eluting stent technology company located in Galway, Ireland. Terms of the acquisition were not disclosed.
  Boston Scientific Corporation January 06, 2009  
• First NxStage home hemodialysis patients celebrate five-year anniversary  NxStage Medical announced that a group of its first patients are celebrating their five-year anniversary of home hemodialysis treatment with the NxStage(R) System One(TM), the first truly portable home hemodialysis machine.
  NxStage Medical, Inc. January 06, 2009  
• ARIAD expands management team with executive appointments  ARIAD Pharmaceuticals announced the appointment of 3 senior executives to ARIAD's management team in newly created positions: Daniel M. Bollag, Ph.D. as senior VP, regulatory affairs and quality, Andreas Woppmann, Ph.D. as VP, manufacturing operations and Kelly M. Schmitz as VP, IT and operations.
  ARIAD Pharmaceuticals, Inc. January 06, 2009  
• MedImmune submits Marketing Authorisation Application in EU for intranasal flu vaccine  MedImmune, the global biologics unit of AstraZeneca, announced that it has submitted a Marketing Authorisation Application (MAA) for its nasal spray live attenuated influenza vaccine (LAIV), which is now being reviewed by the European Medicines Agency (EMEA).
  AstraZeneca January 06, 2009  
• EnviroLogix, Ionian in licensing deal  EnviroLogix, a Portland, Maine-based developer of immunoassays, has closed an exclusive license and technology transfer agreement with Ionian Technologies, a California-based molecular diagnostics firm.
  Mass High Tech January 05, 2009  

   (next 10 articles)